Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Opexa provides additional data for Tovaxin in multiple sclerosis

Oct. 24, 2008

Newron reports positive safety and tolerability results for HF-0220 in AD

Oct. 24, 2008

Recent Xenon, Merck Frosst and GSK patents impart novel analgesic agents

Oct. 24, 2008

Nefopam acts against shivering in healthy volunteers

Oct. 24, 2008

NeurogesX submits NDA for NGX-4010 for postherpetic neuralgia

Oct. 23, 2008

Prostatic acid phosphatase suppresses pain in chronic pain models

Oct. 23, 2008

TorreyPines initiates dosing of first cohort in phase I clinical trial of NGX-426

Oct. 23, 2008

New analgesic agents imparted in recent patents

Oct. 23, 2008

Saiko-keishi-to relieves pain in patients with classical trigeminal neuralgia

Oct. 22, 2008

Avigen's AV-650 did not meet efficacy endpoints in phase IIb MS trial

Oct. 22, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...